# Test Results: writing/specific-aims.md

> ⚠️  Raw model output captured automatically by the cross-model test harness on 2026-06-23.
> This output is **not yet verified**. An author must read the output and set the
> assessment below before this counts as a tested result (see CLAUDE.md, Hard Rules).

## Test Metadata
- **Prompt:** writing/specific-aims.md
- **Model:** nemotron-3-super-120b
- **Model ID (pinned):** Nemotron-3-Super-120B-A12B-NVFP4
- **Endpoint:** https://copilot-dev.cqls.oregonstate.edu/llm/nemotron3-super-120b-nvfp4/v1
- **Date:** 2026-06-23
- **Tester:** cross-model-harness
- **Assembly strategy:** concat
- **Temperature:** 0.0

## Test Input Used
Standard test input from prompt file (`## Test Input`).

## Filled Prompt
```
Context: I am drafting a Specific Aims page for a {GRANT_TYPE: e.g., "NIH R01," "NSF CAREER," "foundation grant"} on {RESEARCH_TOPIC}. The funding agency emphasizes {AGENCY_PRIORITIES: e.g., "mechanistic understanding," "translational potential," "innovative methods"}.

My research plan notes:
{YOUR_NOTES: Include the problem, your approach, preliminary data if any, and what each aim will accomplish}

Target length: {LENGTH: e.g., "1 page," "500 words"}

Task: Draft a Specific Aims page with the following structure:

**Opening paragraph (The Hook):**
- First sentence: Establish the problem and its significance (the "so what")
- Knowledge gap: What critical barrier limits progress?
- Your solution: How does your approach address this gap?
- Long-term goal and overall objective for this proposal

**Specific Aims (2-3 typically):**
For each aim:
- State the aim as a clear objective (what you will do)
- Brief rationale (why this aim matters)
- Approach summary (1-2 sentences on how)
- Expected outcome (what you'll learn)

**Closing paragraph:**
- How the aims integrate and build on each other
- Impact statement: what will be possible after this work that isn't possible now?
- Connection to agency mission (if applicable)

Constraints:
- Use ONLY information from my notes—do not fabricate preliminary data, citations, or capabilities
- Flag any claims that need preliminary data support as [NEEDS PRELIM DATA]
- Flag any citations needed as [CITE]
- Keep within target length
- Use active, confident language—avoid excessive hedging
- Make aims concrete and achievable within the funding period

Output format: Formatted aims page with section headers. Flag gaps for my attention.

Context: I am drafting a Specific Aims page for an NIH R21 (exploratory/developmental) on microbiome biomarkers for colorectal cancer screening. The funding agency emphasizes innovative approaches and high-risk/high-reward research.

My research plan notes:

Problem: Colorectal cancer is the 2nd leading cause of cancer death in the US. Colonoscopy screening is effective but has low compliance (~60%). Non-invasive biomarkers could improve screening rates. Current fecal tests (FIT, Cologuard) have limited sensitivity for adenomas.

My approach: Develop a microbiome-based classifier that detects precancerous adenomas from stool samples. Leverage the known microbiome changes in CRC to detect disease earlier.

Preliminary data:
- Pilot study with 25 adenoma cases, 25 controls
- 16S sequencing identified 12 differentially abundant taxa
- Random forest classifier achieved 78% AUC (needs validation)

Aim 1: Validate and refine the microbiome classifier in an independent cohort
- Partner with GI clinic for prospective sample collection
- Target 100 adenoma cases, 100 controls
- Test classifier performance and refine features

Aim 2: Integrate microbiome data with existing biomarkers (FIT)
- Hypothesis: combined model outperforms either alone
- Collect FIT results alongside microbiome samples
- Build integrated classifier

Innovation: First study to combine microbiome signatures with established screening biomarkers for adenoma detection

My lab: expertise in microbiome bioinformatics, machine learning, established GI collaborations

Target length: 1 page (R21 limit)
```

## Model Output
```


**Specific Aims Page**  
**NIH R21 – Microbiome Biomarkers for Colorectal Cancer Screening**  

---

### Opening Paragraph (The Hook)  
Colorectal cancer (CRC) is the second leading cause of cancer death in the United States [CITE], yet screening colonoscopy remains underutilized, with national compliance rates hovering around 60 % [CITE]. Non‑invasive stool‑based tests such as FIT and Cologuard improve accessibility but exhibit limited sensitivity for detecting precancerous adenomas [CITE], creating a critical barrier to early interception. Our pilot work has identified a stool microbiome signature that distinguishes adenoma cases from controls and yields a random‑forest classifier with 78 % AUC [NEEDS PRELIM DATA]. Leveraging this observation, we propose to develop and validate a microbiome‑based classifier—alone and in combination with FIT—to improve adenoma detection and thereby increase screening uptake. The overall objective of this exploratory R21 is to establish a robust, non‑invasive biomarker platform that can detect adenomas earlier than current fecal tests, laying the groundwork for a future translational screening tool.

---

### Specific Aims  

**Aim 1: Validate and refine the microbiome classifier in an independent cohort**  
*Rationale:* Demonstrating reproducibility of the pilot microbiome signature is essential before clinical translation.  
*Approach:* We will partner with a GI clinic to prospectively collect stool samples from 100 histologically confirmed adenoma cases and 100 age‑ and sex‑matched controls [NEEDS PRELIM DATA] for 16S rRNA sequencing. The existing random‑forest model will be applied to the new data, performance metrics (AUC, sensitivity, specificity) will be calculated, and feature selection will be iteratively refined to optimize classification.  
*Expected Outcome:* A validated microbiome classifier with quantified diagnostic performance and a refined set of microbial features ready for integration with conventional biomarkers.  

**Aim 2: Integrate microbiome data with the established FIT biomarker to develop a combined screening model**  
*Rationale:* FIT detects hemoglobin but misses many adenomas; combining it with microbiome information may capture complementary biological signals and improve overall test accuracy.  
*Approach:* From the same cohort assembled in Aim 1, we will obtain concurrent FIT results. Using machine‑learning approaches (e.g., logistic regression or gradient boosting), we will build an integrated model that combines FIT quantitative output with the refined microbiome feature set. Model performance will be compared against microbiome‑only and FIT‑only classifiers using cross‑validation and independent test‑set evaluation.  
*Expected Outcome:* Evidence of whether a combined microbiome‑FIT model yields superior adenoma detection (higher AUC, sensitivity at fixed specificity) than either modality alone, informing a next‑generation screening strategy.  

---

### Closing Paragraph  
The two aims are sequential and synergistic: Aim 1 establishes the reliability and optimal configuration of the microbiome signal, while Aim 2 tests whether augmenting that signal with FIT improves diagnostic accuracy beyond the current standard. Successful completion will produce a rigorously vetted, non‑invasive biomarker algorithm capable of detecting adenomas with greater sensitivity than FIT alone—addressing the compliance gap by offering a more accurate, patient‑friendly screening option. This work directly aligns with the NIH’s emphasis on innovative, high‑risk/high‑reward approaches that could transform early cancer detection and ultimately reduce CRC mortality.  

---  

*Flags for attention:*  
- Statements regarding CRC epidemiology, colonoscopy compliance, and test sensitivity require literature support [CITE].  
- The pilot‑study AUC of 78 % and the plan to validate/refine the classifier rely on preliminary data; any claim about expected performance improvements should be noted as needing further validation [NEEDS PRELIM DATA].
```

## Assessment

_Machine-suggested (UNCONFIRMED) — drafted by Claude Opus 4.7 on 2026-06-24 to speed T4 review. An author must independently read the Model Output above and set the real Recommendation. Anything labeled here is triage, not domain expert review._

**Machine triage:** Specific Aims (32 lines, 4K chars) with [CITE] and [NEEDS PRELIM DATA] flags inline. All numbers match input. Includes a concise 'Flags for attention' section at end. Substantively complete but more terse than Sonnet/Opus.

**Suggested verdict (UNCONFIRMED):** Pass

**What still needs human verification:**
- All preliminary data numbers match input.
- Cross-model: see Sonnet cell.

## Overall Assessment
- **Recommendation:** PENDING AUTHOR REVIEW
- **Notes:**

## Verification Steps Tested
_Which verification requirements from the prompt were checked, and results._
